Luba Roncari

3.2k total citations · 1 hit paper
16 papers, 2.6k citations indexed

About

Luba Roncari is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Luba Roncari has authored 16 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Genetics. Recurrent topics in Luba Roncari's work include Angiogenesis and VEGF in Cancer (6 papers), Ubiquitin and proteasome pathways (3 papers) and Glioma Diagnosis and Treatment (3 papers). Luba Roncari is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Ubiquitin and proteasome pathways (3 papers) and Glioma Diagnosis and Treatment (3 papers). Luba Roncari collaborates with scholars based in Canada, United States and United Kingdom. Luba Roncari's co-authors include Nelson C. Lau, Abhijit Guha, Patrick Shannon, Kathleen I. Pritchard, Charanjit Sandhu, James A. Wilson, Edmée Franssen, Charles Catzavelos, Yee Ung and Herman Yeger and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Luba Roncari

16 papers receiving 2.5k citations

Hit Papers

Decreased levels of the cell-cycle inhibitor p27Kip1 prot... 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luba Roncari Canada 14 1.8k 1.0k 488 405 350 16 2.6k
Richard Kris United States 25 2.1k 1.2× 1.3k 1.3× 334 0.7× 443 1.1× 257 0.7× 38 3.4k
Olav Engebraaten Norway 29 1.3k 0.7× 925 0.9× 700 1.4× 289 0.7× 277 0.8× 87 2.7k
Marina Holgado-Madruga United States 24 2.4k 1.3× 1.1k 1.0× 378 0.8× 250 0.6× 369 1.1× 33 3.3k
Tim Demuth United States 24 2.0k 1.1× 1.2k 1.1× 624 1.3× 608 1.5× 542 1.5× 43 3.2k
Gerd Munzert Germany 28 1.4k 0.8× 1.1k 1.0× 315 0.6× 243 0.6× 939 2.7× 63 3.1k
Alan H. Shih United States 25 2.7k 1.5× 694 0.7× 618 1.3× 800 2.0× 186 0.5× 37 3.8k
Elizabeth E. Reczek United States 9 2.1k 1.2× 1.2k 1.2× 513 1.1× 122 0.3× 253 0.7× 10 3.2k
Ichiro Nakano United States 28 1.9k 1.0× 798 0.8× 738 1.5× 461 1.1× 175 0.5× 34 2.8k
Igor Garkavtsev United States 25 2.9k 1.6× 1.2k 1.2× 1.2k 2.4× 406 1.0× 251 0.7× 32 4.1k
Teresa Palomero United States 29 3.5k 1.9× 1.0k 1.0× 815 1.7× 383 0.9× 317 0.9× 61 5.4k

Countries citing papers authored by Luba Roncari

Since Specialization
Citations

This map shows the geographic impact of Luba Roncari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luba Roncari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luba Roncari more than expected).

Fields of papers citing papers by Luba Roncari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luba Roncari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luba Roncari. The network helps show where Luba Roncari may publish in the future.

Co-authorship network of co-authors of Luba Roncari

This figure shows the co-authorship network connecting the top 25 collaborators of Luba Roncari. A scholar is included among the top collaborators of Luba Roncari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luba Roncari. Luba Roncari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Narimatsu, Masahiro, Rohit Bose, Melanie Pye, et al.. (2009). Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases. Cell. 137(2). 295–307. 268 indexed citations
2.
Viloria‐Petit, Alicia, Laurent David, Jun Jia, et al.. (2009). A role for the TGFβ-Par6 polarity pathway in breast cancer progression. Proceedings of the National Academy of Sciences. 106(33). 14028–14033. 104 indexed citations
3.
Falter‐Braun, Pascal, Murat Taşan, Matija Dreze, et al.. (2008). An experimentally derived confidence score for binary protein-protein interactions. Nature Methods. 6(1). 91–97. 321 indexed citations
4.
Ding, Hao, Patrick Shannon, Nelson C. Lau, et al.. (2003). Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.. PubMed. 63(5). 1106–13. 99 indexed citations
5.
Feldkamp, Matthias M., Nelson C. Lau, Luba Roncari, & A. Guha. (2001). Isotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status.. PubMed. 61(11). 4425–31. 76 indexed citations
6.
Ding, Hao, Luba Roncari, Xiaoli Wu, et al.. (2001). Expression and hypoxic regulation of angiopoietins in humanastrocytomas. Neuro-Oncology. 3(1). 1–10. 54 indexed citations
7.
Ding, Hao, Luba Roncari, Patrick Shannon, et al.. (2001). Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.. PubMed. 61(9). 3826–36. 205 indexed citations
8.
Ding, Hao, Luba Roncari, Xiaoli Wu, et al.. (2001). Expression and hypoxic regulation of angiopoietins in human astrocytomas. Neuro-Oncology. 3(1). 1–10. 6 indexed citations
9.
Salhia, Bodour, Lilyana Angelov, Luba Roncari, et al.. (2000). Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Research. 883(1). 87–97. 55 indexed citations
10.
Lau, Nelson C., Matthias M. Feldkamp, Luba Roncari, et al.. (2000). Loss of Neurofibromin Is Associated with Activation of RAS/MAPK and PI3-K/AKT Signaling in a Neurofibromatosis 1 Astrocytoma. Journal of Neuropathology & Experimental Neurology. 59(9). 759–767. 128 indexed citations
11.
Ding, Hao, Xiaoli Wu, Luba Roncari, et al.. (2000). Expression and regulation of neuropilin-1 in human astrocytomas. International Journal of Cancer. 88(4). 584–592. 64 indexed citations
12.
Guha, Abhijit, Hao Ding, Luba Roncari, et al.. (2000). 764 Transgenic Mouse Model of Malignant Astrocytoma: Specific Astrocyte Specific Expression of Activated RAS. Neurosurgery. 47(2). 518–518. 2 indexed citations
14.
Angelov, Lilyana, Bodour Salhia, Luba Roncari, Gerald McMahon, & Abhijit Guha. (1999). Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas.. PubMed. 59(21). 5536–41. 92 indexed citations
15.
Okada, Futoshi, Janusz Rak, Brad St. Croix, et al.. (1998). Impact of oncogenes in tumor angiogenesis: Mutant K- ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proceedings of the National Academy of Sciences. 95(7). 3609–3614. 209 indexed citations
16.
Catzavelos, Charles, Nandita Bhattacharya, Yee Ung, et al.. (1997). Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nature Medicine. 3(2). 227–230. 729 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026